Sonnet BioTherapeutics Holdings, Inc.·4

May 28, 4:00 PM ET

Dexter Susan 4

4 · Sonnet BioTherapeutics Holdings, Inc. · Filed May 28, 2021

Insider Transaction Report

Form 4
Period: 2021-05-25
Dexter Susan
Chief Technical Officer
Transactions
  • Tax Payment

    Common Stock

    2021-05-25$1.51/sh10,145$15,31963,468 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $1.49 to $1.55 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Documents

1 file
  • 4
    ownership.xmlPrimary